SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.045-1.9%9:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich Genik who wrote (349)9/1/1999 11:16:00 PM
From: Kramer  Read Replies (1) of 441
 
Rich, the only clues I have are from the BioTrace annual report:

North America - a healthy 39% growth overall, reagent growth was extremely encouraging at 48%...

Turnover and profit on ordinary activities before taxation are derived from on class of business. An analysis of turnover by geographic destination follows: (1000's of British pounds)

Europe 6431
Americas 3474
Rest 536

A pound is about a $1.50, so that's over $5.2 million dollars. I'm not much on British accounting so I'm guessing this is cash flow? Now your guess is as good as mine on how much that would mean to neog, but remember that Jim and Lon are very fussy about making a healthy profit on their deals; If we made a paltry 15% of that it would mean an extra 13 cents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext